Search

Filters

Clear Filters

. Simran, MD, MBBS - Princess Margaret Cancer Centre, University Health Network, University of Toronto

1:30 PM - 1:39 PM ET

1 - Hypofractionated vs. Conventional Fractionated Postmastectomy Radiotherapy in High-Risk Breast Cancer: 10-Year Outcomes from a Phase 3 Randomized Trial
Speaker: Sun, Guang-Yi, MD - National Cancer Center/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical, Beijing, Beijing
8:10 AM - 8:15 AM ET

1 - Hypofractionated vs. Conventional Fractionated Postmastectomy Radiotherapy in High-Risk Breast Cancer: 10-Year Outcomes from a Phase 3 Randomized Trial
Speaker: Sun, Guang-Yi, MD - National Cancer Center/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical, Beijing, Beijing
12:32 PM - 12:52 PM ET

1-2 Fraction Courses of Whole Brain RT
Speaker: Keit, Emily, MD - Moffitt Cancer Center, Tampa, FL
2:00 PM - 2:10 PM ET

10 - Phase II Multi-Institutional Study of Ultralow-Dose (4Gy) Response-Adapted Radiotherapy for Symptomatic Bone Metastases from Multiple Myeloma
Speaker: Ballas, Leslie, MD, FASTRO - Cedars Sinai, Los Angeles, CA
9:30 AM - 9:35 AM ET

10 - Phase II Multi-Institutional Study of Ultralow-Dose (4Gy) Response-Adapted Radiotherapy for Symptomatic Bone Metastases from Multiple Myeloma
Speaker: Ballas, Leslie, MD, FASTRO - Cedars Sinai, Los Angeles, CA
3:00 PM - 3:10 PM ET

100 - Multimodal Modeling of Detailed Cancer Subtypes and Molecular Features from >60,000 Patients with Co-Registered H&E Images and Clinical Tumor Sequencing
Speaker: Boehm, Kevin, MD, PhD - Memorial Sloan Kettering Cancer Center, New York, NY
8:20 AM - 8:25 AM ET

100 - Multimodal Modeling of Detailed Cancer Subtypes and Molecular Features from >60,000 Patients with Co-Registered H&E Images and Clinical Tumor Sequencing
Speaker: Boehm, Kevin, MD, PhD - Memorial Sloan Kettering Cancer Center, New York, NY
3:05 PM - 3:10 PM ET

1000 - Safety of Postoperative Concurrent Capecitabine and Intensity-Modulated Radiotherapy in Triple-Negative Breast Cancer: Results from a Phase II Prospective Study
Speaker: Li, Jiaxuan, MD - Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing
3:10 PM - 3:15 PM ET

1001 - Baseline Cardiovascular Comorbidity Is Associated with Major Adverse Cardiovascular Events after Breast Radiotherapy More Than Tumor Laterality: A Multi-Institutional EHR Cohort
Speaker: Darboe, Mabintou, BS, MPH - Michigan State University, East Lansing, MI
3:15 PM - 3:20 PM ET

1002 - Validation of NSABP B-39/RTOG 0413 Patient-Reported Measures of Breast Cosmesis
Speaker: Torres, Mylin, MD, FASTRO - Emory University School of Medicine, Atlanta, GA
3:20 PM - 3:25 PM ET

1003 - Acute and Long-Term Patient-Reported Outcomes (PRO) by Breast-Q<sup>TM </sup>Prospectively Collected after Accelerated Partial Breast Irradiation (APBI) Delivered Once Daily (QD) vs. Alternating Days (QOD) Post Lumpectomy for Early-Stage Breast Cancer
Speaker: Varghese, Sunitha, MD, MBBS - The University of Kansas Health System, Kansas city, Kansas